Work

Inspire: A Phase 3 Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension (PAH) (Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil NCT03399604) - Exploratory Efficacy Endpoints Analysis at Month 2

Year: 2020

Type: conference-abstract

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7276

Authors: N.S. Hill, J.P. Feldman, S. Sahay, D. Levine, R.F. Roscigno, T. Vaughn, T.M. Bull, INSPIRE Investigators

Institutions: Tufts University, Houston Methodist, The University of Texas at San Antonio Health Science Center, Liquidia Technologies (United States), University of Colorado Anschutz

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3042114205

Cites:

Cited by: 4

Related to: 10